Author

Wang‐Chun Chen

Observed name: Wang-Chun Chen

Institutions: E-Da Hospital, I-Shou University

Observed institutions: E-Da Hospital, I-Shou University

ORCID: 0000-0001-5724-0433

Observed ORCID: 0000-0001-5724-0433

OpenAlex ID: A5070237243

Is moderate resistance training adequate for older adults with sarcopenia? A systematic review and network meta-analysis of RCTs

2023 · Yu Chang Chen, Wang-Chun Chen, et al. · European Review of Aging and Physical Activity · 49

Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials

2021 · Ching-Yi Chen, Wang-Chun Chen, et al. · International Immunopharmacology · 31

Effect of sofosbuvir-based treatment on clinical outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials

2022 · Chi-Kuei Hsu, Ching-Yi Chen, et al. · International Journal of Antimicrobial Agents · 21

Long‐acting beta2‐agonists versus long‐acting muscarinic antagonists in patients with stable COPD : A systematic review and meta‐analysis of randomized controlled trials

2017 · Wang‐Chun Chen, Chi‐Hsien Huang, et al. · Respirology · 19

Chemotherapy or Chemo-Immunotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer: A Meta-Analysis

2021 · Ching-Yi Chen, Wang-Chun Chen, et al. · Immunotherapy · 16

Comparison of clinically indicated replacement and routine replacement of peripheral intravenous catheters: A systematic review and meta-analysis of randomized controlled trials

2022 · Ching-Yi Chen, Wang-Chun Chen, et al. · Frontiers in Medicine · 15

The effect of intravenous immunoglobulins on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials

2022 · Chih-Cheng Lai, Wang-Chun Chen, et al. · Expert Review of Anti-infective Therapy · 13

Comparative safety of immune checkpoint inhibitors and chemotherapy in advanced non-small cell lung cancer: A systematic review and network meta-analysis

2022 · Ching-Yi Chen, Chi-Hsien Huang, et al. · International Immunopharmacology · 13

LABA/LAMA fixed-dose combinations versus LAMA monotherapy in the prevention of COPD exacerbations: a systematic review and meta-analysis

2020 · Ching-Yi Chen, Wang-Chun Chen, et al. · Therapeutic Advances in Respiratory Disease · 13

Clinical efficacy and safety of interferon-β–containing regimens in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials

2021 · Wang-Chun Chen, Chi-Kuei Hsu, et al. · Expert Review of Anti-infective Therapy · 12

The clinical efficacy and safety of mesenchymal stromal cells for patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials

2022 · Ching-Yi Chen, Wang-Chun Chen, et al. · Journal of Infection and Public Health · 7

Anti-MRSA Cephalosporin versus Vancomycin-Based Treatment for Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

2021 · Ching-Yi Chen, Wang-Chun Chen, et al. · Antibiotics · 6

Clinical efficacy and safety of novel lipoglycopeptides in the treatment of acute bacterial skin and skin structure infections: a systematic review and meta-analysis of randomized controlled trials

2021 · Chi-Kuei Hsu, Ching-Yi Chen, et al. · Expert Review of Anti-infective Therapy · 4

Reducing incorrect antibiotic dosing and enhancing prescriber adherence through a real‐time, patient‐specific clinical decision support system: A post‐implementation evaluation

2025 · Shin‐Yi Liang, Cheng‐Loong Liang, et al. · British Journal of Clinical Pharmacology

Works count: 14

Citation count: 219

H-index: 10

I10-index: 10